[HTML][HTML] The mechanisms behind rapid antidepressant effects of ketamine: a systematic review with a focus on molecular neuroplasticity

MJY Kang, E Hawken, GH Vazquez - Frontiers in Psychiatry, 2022 - frontiersin.org
… neurotransmitters, neuromodulatory regulators, or from a trigger … to NMDA receptor ratio
transiently, a marker of increased … -PSD-95, the target of GSK-3 that would promote AMPA-GluA1 …

[HTML][HTML] The ketamine antidepressant story: new insights

TK Alshammari - Molecules, 2020 - mdpi.com
… The aim of this study was to summarize and highlight the … is explicitly linked to the suppression
of NMDAR-mediated burst … , AMPA was found to be an essential element in mediating

[HTML][HTML] Rapid and long-lasting antidepressant-like effects of ketamine and their relationship with the expression of brain enzymes, BDNF, and astrocytes

GSB Viana, EM Do Vale, ARA de Araujo… - Brazilian Journal of …, 2020 - SciELO Brasil
GSK-3: a key regulatory target for ketamine's rapid antidepressant effects mediated by enhanced
AMPA to … the KET antidepressant effect goes beyond the NMDA receptor inhibition and …

Novel rapid-acting glutamatergic modulators: targeting the synaptic plasticity in depression

YT Wang, XL Wang, ST Feng, NH Chen… - Pharmacological …, 2021 - Elsevier
… with rapid-acting antidepressant effects, eg, NMDA receptor … 4-isoxazole propionic acid
(AMPA) receptor, kainate receptor … -Akt signaling can inhabit GSK-3 activity; GSK-3 can inhibit …

Insights into the neurobiology of suicidality: explicating the role of glutamatergic systems through the lens of ketamine

AT Can, JS Mitchell, M Dutton… - Psychiatry and …, 2023 - Wiley Online Library
… -synaptic GluN2Bcontaining NMDAR by ketamine subsequently … linked to improvement of
AMPA throughput, and followed by … GSK-3 inhibitor lithium enhances the antidepressant effects

Ketamine: a tale of two enantiomers

LA Jelen, AH Young, JM Stone - Journal of …, 2021 - journals.sagepub.com
… administrations and cognitive performance was generally found to … GSK-3 as an important
regulatory target for ketamine’s … Although NMDA receptor inhibition and subsequent AMPA

… )-ketamine a potential therapeutic agent for treatment-resistant depression with less detrimental side effects? A review of molecular mechanisms underlying ketamine …

E Scotton, B Antqueviezc, MF de Vasconcelos… - Biochemical …, 2022 - Elsevier
… In summary, ketamine is an NMDAR antagonist developed as a … Hypothetically, these
pyramidal neurons rely on AMPA … , phosphorylation of GSK-3 might be caused by the ketamine-…

[PDF][PDF] Repurposing potential of ketamine: opportunities and challenges

CS Gautam, SS Mahajan, J Sharma… - Indian journal of …, 2020 - journals.sagepub.com
… in BDNF, TrNB and GSK-3-associated pathways in TRD … Enhanced glutamate signalling via
the AMPA receptors in the … Ketamine reduces NMDA receptor-induced neurotoxicity and also …

Glycogen synthase kinase-3 as a key regulator of cognitive function

X Fan, Z Zhao, D Wang, J Xiao - Acta biochimica et biophysica …, 2020 - academic.oup.com
… the structure of GSK-3, the regulation of GSK-3 activity, and its … GSK-3β regulates AMPA
receptor internalization and … of NMDA receptor-mediated signaling by ketamine evoked …

Glycogen synthase kinase-3: The missing link to aberrant circuit function in disorders of cognitive dysfunction?

JD Manduca, RK Thériault, ML Perreault - Pharmacological Research, 2020 - Elsevier
… and potential downstream targets of GSK-3 that may … Thus, in this review, increased activation
of GSK-3 coincident with … susceptibility genes, resulting in NMDAR hypofunction in SZ […